品牌
代理商厂商性质
上海市所在地
Advanced BioScience Laboratories, Inc (ABL) 是马里兰州的生物医学研究公司,专责为生物医学团体提供资源开发和评估各种疫苗,治疗和诊断传染源。ABL是一个高度专业的合同研究组织(CRO ),具有与政府,商业和其他团体合作的丰富经验。ABL致力于预防艾滋病毒和传染病的研究。ABL可以帮助各个领域的产品开发,包括:基础研究,疫苗或产品设计,具有免疫调控的动物模型,为*阶段和第二阶段的临床试验生产cGMP生物制品以及许多其他服务。
ABL有着数以百计的出版物和在艾滋病毒和传染病领域几十年的研究经验。
ABL有着悠久的历史,为客户提供免疫调控服务( ELISA方法,抗原表位的映射,免疫印迹,淋巴细胞的分离,流式细胞仪, elispot等) ,细胞库,并扩增和QC病毒(HIV, SIV, Vaccinia, CMV, HTLV, and FIV)和杂交瘤。
ABL还可以提供一系列广泛的病毒学检测方法的研究使用,如通过NASBA进行RNA的病毒载量测试,抗病毒和病毒中和试验,RIPA,抗原捕获,检测的RT和其它许多相关服务。
ABL还针对HIV,SIV和病毒学研究提供各种特殊产品,包括抗体,抗原,高免疫血清,病毒原液和抗原捕获试剂盒。
Advanced BioScience Laboratories, Inc.报价表 | ||||
货号 | 品名 | 包装 | 价格 | 品牌 |
5421 | HIV-1 p24 Antigen Capture Assay | 96t | 5310 | ABL |
2855 | Vaccinia Virus Titration In BSC-1 Cells | Each | 询价 | ABL |
2859 | Preparation of Vaccinia (From client provided seed) | Each | 询价 | ABL |
2910 | Native Human IL-2 (640 IU/mL) | 50mL | 2880 | ABL |
2911 | Native Human IL-2 (320 IU/mL) | 50mL | 1710 | ABL |
3231 | Direct Pellet (100x) | 1mL | 询价 | ABL |
3232 | Single Band in Sucrose Gradient (10,000x) | 1mL | 询价 | ABL |
3236 | HIV-1 IIIB (Prostak) | 1mL | 133740 | ABL |
3237 | HTLV-I | 1mL | 询价 | ABL |
3238 | SIV-1 | 1mL | 询价 | ABL |
4300 | Anti-p21E (Envelope) | 100ug | 3420 | ABL |
4301 | Anti-gp120 Env (Broadly Reactive) | 100ug | 3420 | ABL |
4302 | Anti-gp120 Env (C2 Domain, Reacts with Types M and O) | 100ug | 3420 | ABL |
4303 | Anti-gp120 Env (Type O) | 100ug | 3420 | ABL |
4304 | Anti-gp41 Env (Type O) | 100ug | 3420 | ABL |
4305 | Anti-Tat | 100ug | 3420 | ABL |
4310 | Anti-p24 Gag (Capsid Protein) | 100ug | 3420 | ABL |
4311 | Anti-gp120 (Conformational) | 100ug | 3420 | ABL |
4312 | Anti-gp41 Env | 100ug | 3420 | ABL |
4313 | Anti-p24 Gag | 100ug | 3420 | ABL |
4314 | Anti-p17 Gag (Cross Reacts with p55) | 100ug | 3420 | ABL |
4315 | Anti-p66/51 (RT) | 100ug | 3420 | ABL |
4317 | Anti-gp120 Env (aa307 to 320) | 100ug | 3420 | ABL |
4318 | Anti-gp120 Env (aa 35 to 108) | 100ug | 3420 | ABL |
4322 | Anti-gp32 Env (Weakly Nuetralizing) | 100ug | 3420 | ABL |
4323 | Anti-p27 Gag | 100ug | 3420 | ABL |
4324 | Anti-p27 Gag (Cross Reacts with HIV-1/2) | 100ug | 3420 | ABL |
4325 | Anti-p17 Gag | 100ug | 3420 | ABL |
4326 | Anti-gp120 Env | 100ug | 3420 | ABL |
4327 | Anti-gp120 Env (Neutralizing) | 100ug | 3420 | ABL |
5407 | Anti-p17 Gag from Rabbit | 1ml | 6210 | ABL |
5408 | Anti-gp120 Env (Clade E, Isolate 93TH976) from Rabbit | 1ml | 6210 | ABL |
5411 | Anti-gp120 Env (Clade C, Isolate 96ZM651) from Rabbit | 1ml | 6210 | ABL |
5412 | Anti-p24 Gag from Rabbit | 1ml | 4680 | ABL |
5413 | Anti-gp120 Env (mac251) from Rabbit | 1ml | 6210 | ABL |
5414 | Anti-gp120 Env (Clade B, Isolate IIIB) from Rabbit | 1ml | 6210 | ABL |
5415 | Anti-tat from Rabbit | 1ml | 6210 | ABL |
5416 | Anti-nef from Rabbit | 1ml | 6210 | ABL |
5417 | Anti-HTLV-I p24 Gag from Goat | 1ml | 4680 | ABL |
5418 | Anti-HTLV-I p24 Gag from Rabbit | 1ml | 4680 | ABL |
5419 | Anti-gp120 Env (Clade A, Isolate 92UG037) | 1ml | 6210 | ABL |
5420 | Anti-gp120 Env (Clade B, Isolate Ba-L) from Rabbit | 1ml | 6210 | ABL |
5422 | Anti-gp120 Env (Clade D, Isolate 57140) from Rabbit | 1ml | 6210 | ABL |
5423 | HIV-1 IIIB gp120 (Native) | 100ug | 16650 | ABL |
5424 | HIV-1 451 gp120 (Native) | 100ug | 15570 | ABL |
5425 | HIV-1 IIIB p24 | 100ug | 9090 | ABL |
5426 | HIV-1 IIIB gp140 (Native) | 100ug | 15570 | ABL |
5427 | HIV-1 451 gp140 (Native) | 100ug | 15570 | ABL |
5428 | SIV mac251 gp120 (Native) | 100ug | 15570 | ABL |
5429 | HIV-1 gp120 Antigen Capture Assay | 96t | 11160 | ABL |
5430 | SIV mac251 p27 (Native) | 100ug | 9360 | ABL |
5436 | SIV p27 Antigen Capture Assay | 96t | 6210 | ABL |
5441 | HIV-1 IIIB Biologically Active TAT (Recombinant) | 1 mg | 52848 | ABL |
5442 | HIV-1 IIIB Biologically Active TAT (Recombinant) | 100ug | 5292 | ABL |
5447 | Bulk HIV-1 p24 | 10x96t | 42750 | ABL |
5450 | Bulk SIV p27 | 10x96t | 53910 | ABL |